GlassScriptPhysician profile
Gregory W Hanson
NPI 1043280910
$1,123.68
in general payments reported to CMS, 2019-2025
17 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.37 · 2020: $257 · 2021: $110 · 2022: $137 · 2023: $150 · 2024: $144 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.71 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $185.70 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $109.01 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $108.42 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $84.51 | 2020-2024 | Airsupra |
| Glaxosmithkline, LLC. | $80.82 | 2019-2023 | Arexvy, Shingrix |
| Amgen INC. | $79.50 | 2019-2025 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $60.24 | 2022-2024 | |
| Novo Nordisk INC | $57.36 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $44.50 | 2020-2023 | Xarelto |
| Astellas Pharma US INC | $18.34 | 2025 | Xtandi |
| Abbott Laboratories | $18.16 | 2025 | Proclaim |
| Genentech USA, INC. | $15.44 | 2021 | |
| Dexcom, INC. | $13.78 | 2023 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $13.33 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $13.21 | 2022 | |
| Abbvie INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.